Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 17/20 | 0.54 |
| ▸ | CTSS | P25774 | 1/20 | 0.40 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.40 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.37 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.37 |
| ▸ | CCR1 | P32246 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5942176 | 0.95 | CTSK (0.52) | CTSKCTSS | |
| SCHEMBL5942007 | 0.94 | CTSK (0.52) | CTSKCTSSSMYD3TAS1R3TAS1R1 | |
| SCHEMBL5941657 | 0.91 | CTSK (0.56) | CTSKCTSSTAS1R3TAS1R1CCR1 | |
| SCHEMBL4041016 | 0.89 | CTSK (0.56) | CTSKCTSSSMYD3 | |
| SCHEMBL4036968 | 0.88 | CTSK (0.58) | CTSKCTSSSMYD3 | |
| SCHEMBL4043242 | 0.87 | CTSK (0.57) | CTSKCTSSSMYD3 | |
| SCHEMBL4040771 | 0.87 | CTSK (0.57) | CTSKCTSSSMYD3 | |
| SCHEMBL5942133 | 0.87 | CTSK (0.55) | CTSKCTSS | |
| SCHEMBL5942311 | 0.87 | CTSK (0.63) | CTSKCTSS | |
| SCHEMBL4041784 | 0.86 | CTSK (0.59) | CTSKCTSSSMYD3CCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060100431-A1 | Biologically active compounds | AMURA THERAPEUTICS LIMITED (GB) | 2006-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060100431-A1 | Biologically active compounds | SOST, CTSK, CTSS | CTSK 2/4885CTSS 3/4885SMYD3 4011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.